Clinical Trial Update: Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Clinical trial update indicating that a Phase 2 intrathecal monoclonal antibody therapy study in progressive multiple sclerosis has completed. The document does…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Intrathecal monoclonal antibody therapy

Snippet

Sponsor: Anders Svenningsson | Conditions: Progressive Multiple Sclerosis | Phase 2 | Status: COMPLETED